According to this latest study, the 2021 growth of Colloids (Blood Plasma) will have significant change from previous year. By the most conservative estimates of global Colloids (Blood Plasma) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 407.9 million in 2020. Over the next five years the Colloids (Blood Plasma) market will register a -2.6% CAGR in terms of revenue, the global market size will reach US$ 367.2 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Colloids (Blood Plasma) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi(China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Colloids (Blood Plasma) Consumption 2016-2026
2.1.2 Colloids (Blood Plasma) Consumption CAGR by Region
2.2 Colloids (Blood Plasma) Segment by Type
2.2.1 Natural Type Colloids (Blood Plasma)
2.2.2 Synthetic Type Colloids (Blood Plasma)
2.3 Colloids (Blood Plasma) Sales by Type
2.3.1 Global Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
2.3.2 Global Colloids (Blood Plasma) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Colloids (Blood Plasma) Sale Price by Type (2016-2021)
2.4 Colloids (Blood Plasma) Segment by Application
2.4.1 Extensive Burns
2.4.2 Massive Blood or Plasma Loss
2.4.3 Hypovolemic Shock
2.4.4 Others
2.5 Colloids (Blood Plasma) Sales by Application
2.5.1 Global Colloids (Blood Plasma) Sale Market Share by Application (2016-2021)
2.5.2 Global Colloids (Blood Plasma) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Colloids (Blood Plasma) Sale Price by Application (2016-2021)
3 Global Colloids (Blood Plasma) by Company
3.1 Global Colloids (Blood Plasma) Sales Market Share by Company
3.1.1 Global Colloids (Blood Plasma) Sales by Company (2019-2021)
3.1.2 Global Colloids (Blood Plasma) Sales Market Share by Company (2019-2021)
3.2 Global Colloids (Blood Plasma) Revenue Market Share by Company
3.2.1 Global Colloids (Blood Plasma) Revenue by Company (2019-2021)
3.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Company (2019-2021)
3.3 Global Colloids (Blood Plasma) Sale Price by Company
3.4 Global Manufacturers Colloids (Blood Plasma) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Colloids (Blood Plasma) Product Location Distribution
3.4.2 Players Colloids (Blood Plasma) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Colloids (Blood Plasma) by Region
4.1 Global Colloids (Blood Plasma) by Region
4.1.1 Global Colloids (Blood Plasma) Sales by Region
4.1.2 Global Colloids (Blood Plasma) Revenue by Region
4.2 Americas Colloids (Blood Plasma) Sales Growth
4.3 APAC Colloids (Blood Plasma) Sales Growth
4.4 Europe Colloids (Blood Plasma) Sales Growth
4.5 Middle East & Africa Colloids (Blood Plasma) Sales Growth
5 Americas
5.1 Americas Colloids (Blood Plasma) Sales by Country
5.1.1 Americas Colloids (Blood Plasma) Sales by Country (2016-2021)
5.1.2 Americas Colloids (Blood Plasma) Revenue by Country (2016-2021)
5.2 Americas Colloids (Blood Plasma) Sales by Type
5.3 Americas Colloids (Blood Plasma) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Colloids (Blood Plasma) Sales by Region
6.1.1 APAC Colloids (Blood Plasma) Sales by Region (2016-2021)
6.1.2 APAC Colloids (Blood Plasma) Revenue by Region (2016-2021)
6.2 APAC Colloids (Blood Plasma) Sales by Type
6.3 APAC Colloids (Blood Plasma) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Colloids (Blood Plasma) by Country
7.1.1 Europe Colloids (Blood Plasma) Sales by Country (2016-2021)
7.1.2 Europe Colloids (Blood Plasma) Revenue by Country (2016-2021)
7.2 Europe Colloids (Blood Plasma) Sales by Type
7.3 Europe Colloids (Blood Plasma) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Colloids (Blood Plasma) by Country
8.1.1 Middle East & Africa Colloids (Blood Plasma) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Colloids (Blood Plasma) Revenue by Country (2016-2021)
8.2 Middle East & Africa Colloids (Blood Plasma) Sales by Type
8.3 Middle East & Africa Colloids (Blood Plasma) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Colloids (Blood Plasma) Distributors
10.3 Colloids (Blood Plasma) Customer
11 Global Colloids (Blood Plasma) Market Forecast
11.1 Global Colloids (Blood Plasma) Forecast by Region
11.1.1 Global Colloids (Blood Plasma) Forecast by Regions (2021-2026)
11.2.2 Global Colloids (Blood Plasma) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Colloids (Blood Plasma) Forecast by Type
11.7 Global Colloids (Blood Plasma) Forecast by Application
12 Key Players Analysis
12.1 CSL Behring
12.1.1 CSL Behring Company Information
12.1.2 CSL Behring Colloids (Blood Plasma) Product Offered
12.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 CSL Behring Main Business Overview
12.1.5 CSL Behring Latest Developments
12.2 Baxter
12.2.1 Baxter Company Information
12.2.2 Baxter Colloids (Blood Plasma) Product Offered
12.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Baxter Main Business Overview
12.2.5 Baxter Latest Developments
12.3 Grifols
12.3.1 Grifols Company Information
12.3.2 Grifols Colloids (Blood Plasma) Product Offered
12.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Grifols Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Octapharma
12.4.1 Octapharma Company Information
12.4.2 Octapharma Colloids (Blood Plasma) Product Offered
12.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Octapharma Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Kedrion
12.5.1 Kedrion Company Information
12.5.2 Kedrion Colloids (Blood Plasma) Product Offered
12.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Kedrion Main Business Overview
12.5.5 Kedrion Latest Developments
12.6 Shanghai Raas
12.6.1 Shanghai Raas Company Information
12.6.2 Shanghai Raas Colloids (Blood Plasma) Product Offered
12.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Shanghai Raas Main Business Overview
12.6.5 Shanghai Raas Latest Developments
12.7 CTBB
12.7.1 CTBB Company Information
12.7.2 CTBB Colloids (Blood Plasma) Product Offered
12.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 CTBB Main Business Overview
12.7.5 CTBB Latest Developments
12.8 Hualan Bio
12.8.1 Hualan Bio Company Information
12.8.2 Hualan Bio Colloids (Blood Plasma) Product Offered
12.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Hualan Bio Main Business Overview
12.8.5 Hualan Bio Latest Developments
12.9 Rongsheng Pharmaceutical
12.9.1 Rongsheng Pharmaceutical Company Information
12.9.2 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Offered
12.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Rongsheng Pharmaceutical Main Business Overview
12.9.5 Rongsheng Pharmaceutical Latest Developments
12.10 Boya Rongsheng
12.10.1 Boya Rongsheng Company Information
12.10.2 Boya Rongsheng Colloids (Blood Plasma) Product Offered
12.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Boya Rongsheng Main Business Overview
12.10.5 Boya Rongsheng Latest Developments
12.11 B. Braun Medical
12.11.1 B. Braun Medical Company Information
12.11.2 B. Braun Medical Colloids (Blood Plasma) Product Offered
12.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 B. Braun Medical Main Business Overview
12.11.5 B. Braun Medical Latest Developments
12.12 Fresenius Kabi
12.12.1 Fresenius Kabi Company Information
12.12.2 Fresenius Kabi Colloids (Blood Plasma) Product Offered
12.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Fresenius Kabi Main Business Overview
12.12.5 Fresenius Kabi Latest Developments
12.13 HOSPIRA
12.13.1 HOSPIRA Company Information
12.13.2 HOSPIRA Colloids (Blood Plasma) Product Offered
12.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 HOSPIRA Main Business Overview
12.13.5 HOSPIRA Latest Developments
12.14 Axa parenterals
12.14.1 Axa parenterals Company Information
12.14.2 Axa parenterals Colloids (Blood Plasma) Product Offered
12.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Axa parenterals Main Business Overview
12.14.5 Axa parenterals Latest Developments
12.15 Fresenius Kabi(China)
12.15.1 Fresenius Kabi(China) Company Information
12.15.2 Fresenius Kabi(China) Colloids (Blood Plasma) Product Offered
12.15.3 Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Fresenius Kabi(China) Main Business Overview
12.15.5 Fresenius Kabi(China) Latest Developments
12.16 CR Double-Crane
12.16.1 CR Double-Crane Company Information
12.16.2 CR Double-Crane Colloids (Blood Plasma) Product Offered
12.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 CR Double-Crane Main Business Overview
12.16.5 CR Double-Crane Latest Developments
12.17 Kelun Group
12.17.1 Kelun Group Company Information
12.17.2 Kelun Group Colloids (Blood Plasma) Product Offered
12.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Kelun Group Main Business Overview
12.17.5 Kelun Group Latest Developments
12.18 Shandong Qidu Pharmaceutical
12.18.1 Shandong Qidu Pharmaceutical Company Information
12.18.2 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Offered
12.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Shandong Qidu Pharmaceutical Main Business Overview
12.18.5 Shandong Qidu Pharmaceutical Latest Developments
12.19 Shandong Hualu Pharmaceutical
12.19.1 Shandong Hualu Pharmaceutical Company Information
12.19.2 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Offered
12.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Shandong Hualu Pharmaceutical Main Business Overview
12.19.5 Shandong Hualu Pharmaceutical Latest Developments
12.20 Minsheng Pharma
12.20.1 Minsheng Pharma Company Information
12.20.2 Minsheng Pharma Colloids (Blood Plasma) Product Offered
12.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Minsheng Pharma Main Business Overview
12.20.5 Minsheng Pharma Latest Developments
12.21 Kanglepharm
12.21.1 Kanglepharm Company Information
12.21.2 Kanglepharm Colloids (Blood Plasma) Product Offered
12.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 Kanglepharm Main Business Overview
12.21.5 Kanglepharm Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Colloids (Blood Plasma) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Natural Type Colloids (Blood Plasma)
Table 3. Major Players of Synthetic Type Colloids (Blood Plasma)
Table 4. Global Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 5. Global Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 6. Global Colloids (Blood Plasma) Revenue by Type (2016-2021) & ($ million)
Table 7. Global Colloids (Blood Plasma) Revenue Market Share by Type (2016-2021)
Table 8. Global Colloids (Blood Plasma) Sale Price by Type (2016-2021)
Table 9. Global Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 10. Global Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 11. Global Colloids (Blood Plasma) Value by Application (2016-2021)
Table 12. Global Colloids (Blood Plasma) Revenue Market Share by Application (2016-2021)
Table 13. Global Colloids (Blood Plasma) Sale Price by Application (2016-2021)
Table 14. Global Colloids (Blood Plasma) Sales by Company (2019-2021) & (MT)
Table 15. Global Colloids (Blood Plasma) Sales Market Share by Company (2019-2021)
Table 16. Global Colloids (Blood Plasma) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Colloids (Blood Plasma) Revenue Market Share by Company (2019-2021)
Table 18. Global Colloids (Blood Plasma) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Colloids (Blood Plasma) Producing Area Distribution and Sales Area
Table 20. Players Colloids (Blood Plasma) Products Offered
Table 21. Colloids (Blood Plasma) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Colloids (Blood Plasma) Sales by Region (2016-2021) (MT)
Table 25. Global Colloids (Blood Plasma) Sales Market Share by Region (2016-2021)
Table 26. Global Colloids (Blood Plasma) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Colloids (Blood Plasma) Revenue Market Share by Region (2016-2021)
Table 28. Americas Colloids (Blood Plasma) Sales by Country (2016-2021) & (MT)
Table 29. Americas Colloids (Blood Plasma) Sales Market Share by Country (2016-2021)
Table 30. Americas Colloids (Blood Plasma) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Colloids (Blood Plasma) Revenue Market Share by Country (2016-2021)
Table 32. Americas Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 33. Americas Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 34. Americas Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 35. Americas Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 36. APAC Colloids (Blood Plasma) Sales by Region (2016-2021) & (MT)
Table 37. APAC Colloids (Blood Plasma) Sales Market Share by Region (2016-2021)
Table 38. APAC Colloids (Blood Plasma) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Colloids (Blood Plasma) Revenue Market Share by Region (2016-2021)
Table 40. APAC Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 41. APAC Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 42. APAC Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 43. APAC Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 44. Europe Colloids (Blood Plasma) Sales by Country (2016-2021) & (MT)
Table 45. Europe Colloids (Blood Plasma) Sales Market Share by Country (2016-2021)
Table 46. Europe Colloids (Blood Plasma) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Colloids (Blood Plasma) Revenue Market Share by Country (2016-2021)
Table 48. Europe Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 49. Europe Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 50. Europe Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 51. Europe Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Colloids (Blood Plasma) Sales by Country (2016-2021) & (MT)
Table 53. Middle East & Africa Colloids (Blood Plasma) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Colloids (Blood Plasma) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Colloids (Blood Plasma) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 57. Middle East & Africa Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 59. Middle East & Africa Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Colloids (Blood Plasma)
Table 61. Key Application and Potential Industries of Colloids (Blood Plasma)
Table 62. Key Challenges of Colloids (Blood Plasma)
Table 63. Key Trends of Colloids (Blood Plasma)
Table 64. Colloids (Blood Plasma) Distributors List
Table 65. Colloids (Blood Plasma) Customer List
Table 66. Global Colloids (Blood Plasma) Sales Forecast by Region (2021-2026) & (MT)
Table 67. Global Colloids (Blood Plasma) Consumption Market Forecast by Region
Table 68. Global Colloids (Blood Plasma) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Colloids (Blood Plasma) Sales Forecast by Country (2021-2026) & (MT)
Table 71. Americas Colloids (Blood Plasma) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Colloids (Blood Plasma) Sales Forecast by Region (2021-2026) & (MT)
Table 73. APAC Colloids (Blood Plasma) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Colloids (Blood Plasma) Sales Forecast by Country (2021-2026) & (MT)
Table 75. Europe Colloids (Blood Plasma) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Colloids (Blood Plasma) Sales Forecast by Country (2021-2026) & (MT)
Table 77. Middle East & Africa Colloids (Blood Plasma) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Colloids (Blood Plasma) Sales Forecast by Type (2021-2026) & (MT)
Table 79. Global Colloids (Blood Plasma) Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Colloids (Blood Plasma) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Colloids (Blood Plasma) Sales Forecast by Application (2021-2026) & (MT)
Table 83. Global Colloids (Blood Plasma) Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Colloids (Blood Plasma) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Application (2021-2026)
Table 86. CSL Behring Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 87. CSL Behring Colloids (Blood Plasma) Product Offered
Table 88. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 89. CSL Behring Main Business
Table 90. CSL Behring Latest Developments
Table 91. Baxter Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 92. Baxter Colloids (Blood Plasma) Product Offered
Table 93. Baxter Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 94. Baxter Main Business
Table 95. Baxter Latest Developments
Table 96. Grifols Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 97. Grifols Colloids (Blood Plasma) Product Offered
Table 98. Grifols Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 99. Grifols Main Business
Table 100. Grifols Latest Developments
Table 101. Octapharma Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 102. Octapharma Colloids (Blood Plasma) Product Offered
Table 103. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 104. Octapharma Main Business
Table 105. Octapharma Latest Developments
Table 106. Kedrion Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 107. Kedrion Colloids (Blood Plasma) Product Offered
Table 108. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 109. Kedrion Main Business
Table 110. Kedrion Latest Developments
Table 111. Shanghai Raas Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 112. Shanghai Raas Colloids (Blood Plasma) Product Offered
Table 113. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 114. Shanghai Raas Main Business
Table 115. Shanghai Raas Latest Developments
Table 116. CTBB Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 117. CTBB Colloids (Blood Plasma) Product Offered
Table 118. CTBB Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 119. CTBB Main Business
Table 120. CTBB Latest Developments
Table 121. Hualan Bio Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 122. Hualan Bio Colloids (Blood Plasma) Product Offered
Table 123. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 124. Hualan Bio Main Business
Table 125. Hualan Bio Latest Developments
Table 126. Rongsheng Pharmaceutical Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 127. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Offered
Table 128. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 129. Rongsheng Pharmaceutical Main Business
Table 130. Rongsheng Pharmaceutical Latest Developments
Table 131. Boya Rongsheng Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 132. Boya Rongsheng Colloids (Blood Plasma) Product Offered
Table 133. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 134. Boya Rongsheng Main Business
Table 135. Boya Rongsheng Latest Developments
Table 136. B. Braun Medical Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 137. B. Braun Medical Colloids (Blood Plasma) Product Offered
Table 138. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 139. B. Braun Medical Main Business
Table 140. B. Braun Medical Latest Developments
Table 141. Fresenius Kabi Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 142. Fresenius Kabi Colloids (Blood Plasma) Product Offered
Table 143. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 144. Fresenius Kabi Main Business
Table 145. Fresenius Kabi Latest Developments
Table 146. HOSPIRA Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 147. HOSPIRA Colloids (Blood Plasma) Product Offered
Table 148. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 149. HOSPIRA Main Business
Table 150. HOSPIRA Latest Developments
Table 151. Axa parenterals Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 152. Axa parenterals Colloids (Blood Plasma) Product Offered
Table 153. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 154. Axa parenterals Main Business
Table 155. Axa parenterals Latest Developments
Table 156. Fresenius Kabi(China) Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 157. Fresenius Kabi(China) Colloids (Blood Plasma) Product Offered
Table 158. Fresenius Kabi(China) Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 159. Fresenius Kabi(China) Main Business
Table 160. Fresenius Kabi(China) Latest Developments
Table 161. CR Double-Crane Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 162. CR Double-Crane Colloids (Blood Plasma) Product Offered
Table 163. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 164. CR Double-Crane Main Business
Table 165. CR Double-Crane Latest Developments
Table 166. Kelun Group Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 167. Kelun Group Colloids (Blood Plasma) Product Offered
Table 168. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 169. Kelun Group Main Business
Table 170. Kelun Group Latest Developments
Table 171. Shandong Qidu Pharmaceutical Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 172. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Offered
Table 173. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 174. Shandong Qidu Pharmaceutical Main Business
Table 175. Shandong Qidu Pharmaceutical Latest Developments
Table 176. Shandong Hualu Pharmaceutical Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 177. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Offered
Table 178. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 179. Shandong Hualu Pharmaceutical Main Business
Table 180. Shandong Hualu Pharmaceutical Latest Developments
Table 181. Minsheng Pharma Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 182. Minsheng Pharma Colloids (Blood Plasma) Product Offered
Table 183. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 184. Minsheng Pharma Main Business
Table 185. Minsheng Pharma Latest Developments
Table 186. Kanglepharm Basic Information, Colloids (Blood Plasma) Manufacturing Base, Sales Area and Its Competitors
Table 187. Kanglepharm Colloids (Blood Plasma) Product Offered
Table 188. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 189. Kanglepharm Main Business
Table 190. Kanglepharm Latest Developments
List of Figures
Figure 1. Picture of Colloids (Blood Plasma)
Figure 2. Colloids (Blood Plasma) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Colloids (Blood Plasma) Sales Growth Rate 2016-2026 (MT)
Figure 7. Global Colloids (Blood Plasma) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Colloids (Blood Plasma) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Natural Type Colloids (Blood Plasma)
Figure 10. Product Picture of Synthetic Type Colloids (Blood Plasma)
Figure 11. Global Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 12. Global Colloids (Blood Plasma) Revenue Market Share by Type (2016-2021)
Figure 13. Colloids (Blood Plasma) Consumed in Extensive Burns
Figure 14. Global Colloids (Blood Plasma) Market: Extensive Burns (2016-2021) & (MT)
Figure 15. Colloids (Blood Plasma) Consumed in Massive Blood or Plasma Loss
Figure 16. Global Colloids (Blood Plasma) Market: Massive Blood or Plasma Loss (2016-2021) & (MT)
Figure 17. Colloids (Blood Plasma) Consumed in Hypovolemic Shock
Figure 18. Global Colloids (Blood Plasma) Market: Hypovolemic Shock (2016-2021) & (MT)
Figure 19. Colloids (Blood Plasma) Consumed in Others
Figure 20. Global Colloids (Blood Plasma) Market: Others (2016-2021) & (MT)
Figure 21. Global Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Figure 22. Global Colloids (Blood Plasma) Revenue Market Share by Application in 2020
Figure 23. Colloids (Blood Plasma) Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Colloids (Blood Plasma) Revenue Market Share by Company in 2020
Figure 25. Global Colloids (Blood Plasma) Sales Market Share by Regions (2016-2021)
Figure 26. Global Colloids (Blood Plasma) Revenue Market Share by Region in 2020
Figure 27. Americas Colloids (Blood Plasma) Sales 2016-2021 (MT)
Figure 28. Americas Colloids (Blood Plasma) Revenue 2016-2021 ($ Millions)
Figure 29. APAC Colloids (Blood Plasma) Sales 2016-2021 (MT)
Figure 30. APAC Colloids (Blood Plasma) Revenue 2016-2021 ($ Millions)
Figure 31. Europe Colloids (Blood Plasma) Sales 2016-2021 (MT)
Figure 32. Europe Colloids (Blood Plasma) Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Colloids (Blood Plasma) Sales 2016-2021 (MT)
Figure 34. Middle East & Africa Colloids (Blood Plasma) Revenue 2016-2021 ($ Millions)
Figure 35. Americas Colloids (Blood Plasma) Sales Market Share by Country in 2020
Figure 36. Americas Colloids (Blood Plasma) Revenue Market Share by Country in 2020
Figure 37. Americas Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 38. Americas Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 39. United States Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Colloids (Blood Plasma) Sales Market Share by Region in 2020
Figure 44. APAC Colloids (Blood Plasma) Revenue Market Share by Regions in 2020
Figure 45. APAC Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 46. APAC Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 47. China Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Colloids (Blood Plasma) Sales Market Share by Country in 2020
Figure 54. Europe Colloids (Blood Plasma) Revenue Market Share by Country in 2020
Figure 55. Europe Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 56. Europe Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 57. Germany Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Colloids (Blood Plasma) Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Colloids (Blood Plasma) Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 66. Egypt Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Colloids (Blood Plasma) Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles